• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage
  • Life Sciences
  • Research

GoodRx Launches Real-Time Benefit Check in Provider Mode

by Jasmine Pennic 08/31/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– GoodRx, a resource for healthcare savings and information launches its real-time benefit check (RTBC) in Provider Mode.

– Developed in collaboration with AssistRx, the advanced therapy initiation and patient solutions provider, real-time benefit check gives healthcare professionals (HCPs) immediate access to eligible patients’ insurance coverage and greater visibility into the cost of brand and specialty drug prescriptions at the point of prescribing.

Comprehensive Cost Information At The Point of Prescribing

Real-time benefit check is easy and seamless for providers to use. After healthcare professionals log into GoodRx Provider Mode, they can check a patient’s insurance coverage with just a few pieces of information – patient name, date of birth, gender, and zip code. Provider Mode is easily accessed through the web on any device. It can be used alongside existing healthcare technology systems and includes cost comparison tools, faster savings with GoodRx coupons, customized news feeds, enrollment forms for specialty hubs, and brand drug savings options that are not available in traditional electronic health records. HCPs can also seamlessly share available GoodRx savings with their patients using a QR code, without having to share a personal email address or phone number with the recipient.

Real-time benefit check also has the potential to deliver significant value to GoodRx’s pharma manufacturer partners. Pharma manufacturers spend a lot of time and resources educating HCPs about their medication access solutions. Through Provider Mode, these manufacturers can help raise awareness with high-intent HCPs who are searching for brand and specialty medications on GoodRx. Cost and affordability are often major barriers to taking medications as prescribed, so by surfacing if a patient is eligible for a copay card or savings programs at the point of prescription, real-time benefit check delivers more transparency in the prescribing workflow. This can ultimately enable manufacturers to reach large, highly motivated audiences at a key juncture in the provider and patient journey, with the goal of driving greater healthcare access and less script abandonment.

Over 550,000 HCPs have used Provider Mode to date, and GoodRx’s comprehensive price comparison features, which now include real-time benefit check, enable them to see the cost of a prescription with insurance, with GoodRx, or with a manufacturer’s savings program.

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

Featured Insights

2025 EMR Software Pricing Guide

2025 EMR Software Pricing Guide

Featured Interview

Paradigm Shift in Diabetes Care with Studio Clinics: Q&A with Reach7 Founder Chun Yong

Most-Read

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Soars in NASDAQ Debut, Signaling Digital Health IPO Rebound

Medtronic to Separate Diabetes Business into New Standalone Company

Medtronic to Separate Diabetes Business into New Standalone Company

White House, IBM Partner to Fight COVID-19 Using Supercomputers

HHS Sets Pricing Targets for Trump’s EO on Most-Favored-Nation Drug Pricing

23andMe to Mine Genetic Data for Drug Discovery

Regeneron to Acquire Key 23andMe Assets for $256M, Pledges Continuity of Consumer Genome Services

CureIS Healthcare Sues Epic: Alleges Anti-Competitive Practices & Trade Secret Theft

The Evolving Role of Physician Advisors: Bridging the Gap Between Clinicians and Administrators

The Evolving Physician Advisor: From UM to Value-Based Care & AI

UnitedHealth Group Names Stephen Hemsley CEO as Andrew Witty Steps Down

UnitedHealth CEO Andrew Witty Steps Down, Stephen Hemsley Returns as CEO

Omada Health Files for IPO

Omada Health Files for IPO

Blue Cross Blue Shield of Massachusetts Launches "CloseKnit" Virtual-First Primary Care Option

Blue Cross Blue Shield of Massachusetts Launches “CloseKnit” Virtual-First Primary Care Option

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Osteoboost Launches First FDA-Cleared Prescription Wearable Nationwide to Combat Low Bone Density

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Submit An Op-Ed
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |